Germline and sporadic cancers driven by the RAS pathway: parallels and contrasts
Open Access
- 30 March 2020
- journal article
- review article
- Published by Elsevier BV in Annals of Oncology
- Vol. 31 (7), 873-883
- https://doi.org/10.1016/j.annonc.2020.03.291
Abstract
No abstract availableKeywords
Funding Information
- Cancer Research UK
This publication has 99 references indexed in Scilit:
- A Landscape of Driver Mutations in MelanomaCell, 2012
- Mortality in neurofibromatosis 1: in North West England: an assessment of actuarial survival in a region of the UK since 1989European Journal of Human Genetics, 2011
- Cancer in Noonan, Costello, cardiofaciocutaneous and LEOPARD syndromesSeminars in Medical Genetics, Part C of the American Journal of Medical Genetics, 2011
- Cardio‐facio‐cutaneous syndrome: Does genotype predict phenotype?Seminars in Medical Genetics, Part C of the American Journal of Medical Genetics, 2011
- Germline KRAS mutations cause aberrant biochemical and physical properties leading to developmental disordersHuman Mutation, 2010
- Heterozygous Germline Mutations in the CBL Tumor-Suppressor Gene Cause a Noonan Syndrome-like PhenotypeAmerican Journal of Human Genetics, 2010
- Genetic analysis of Ras signalling pathways in cell proliferation, migration and survivalThe EMBO Journal, 2010
- Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndromeNature Genetics, 2006
- Germline KRAS mutations cause Noonan syndromeNature Genetics, 2006
- Germline mutations in HRAS proto-oncogene cause Costello syndromeNature Genetics, 2005